<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of this study was to determine whether antireflux surgery is more effective in producing loss of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> located only at the gastroesophageal junction than it has been in patients with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> extending up into the distal esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>SUMMARY BACKGROUND DATA: Biopsies of a <z:mpath ids='MPATH_458'>normal</z:mpath> appearing gastroesophageal junction will demonstrate cardiac mucosa containing goblet cells--the hallmark of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>--in 10% to 15% of patients who are evaluated for symptoms of <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The incidence of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus and cardia is rising faster than any other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in America, and most of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are found adjacent to areas of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Antireflux surgery in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> may provide protection from progression to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>; however, it does not reliably cause regression of the <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Less is known about the potential for <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> limited to the cardia (CIM) to regress </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Sixty patients with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> of the esophagus or cardia had antireflux surgery </plain></SENT>
<SENT sid="6" pm="."><plain>Patients in the intestinal (CIM) group (n = 15) had no endoscopically visible segment of columnar epithelium </plain></SENT>
<SENT sid="7" pm="."><plain>Patients in the Barrett's group (n = 45) had columnar epithelium visible within the esophagus </plain></SENT>
<SENT sid="8" pm="."><plain>Median follow-up was 25 months in each group </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Postoperative biopsies showed complete loss of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> in 73% of the patients with CIM compared with 4.4% of the patients with Barrett's </plain></SENT>
<SENT sid="10" pm="."><plain>Low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, present in 10 patients preoperatively, regressed in 7 patients (70%) </plain></SENT>
<SENT sid="11" pm="."><plain>No patient progressed to high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Loss of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> after antireflux surgery is rare in patients with Barrett's, but occurred in most patients with CIM </plain></SENT>
<SENT sid="13" pm="."><plain>This suggests that cardiac epithelium is dynamic and that microscopic areas of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> are able to regress much more frequently than longer, visible segments of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
</text></document>